Stem Cell Research
Publisher: Elsevier · ISSN 1873-5061 · 43 articles
- Establishment of a human induced pluripotent stem cell line, KMUGMCi011-A, from a patient bearing a frameshift mutation in the KMT2D gene leading Kabuki syndrome 1
- Establishment of two iPSC lines from ALS patients carrying mutations in SQSTM1 and TBK1 genes
- Generation of an induced pluripotent stem cell line from a long QT syndrome type 1 patient carrying the KCNQ1 c.343G > A p.(E115K) variant
- Generation of the induced pluripotent stem cell line SHUTCMi001-A from a patient with double primary lung and colon cancers
- Generation of an induced pluripotent stem cell line, JHUi010-A, from an arrhythmogenic cardiomyopathy patient harboring pathogenic DSG2 variant c.2358delA
- Generation of human induced pluripotent stem cell line (CMCi015-A) from a patient with nephronophthisis harboring compound heterozygous loss-of-function variants in the NPHP4 gene
- Generation and characterization of a human iPSC line (XACHi022-A) derived from an asymptomatic carrier of the GAA c.2051C > A (p.P684Q) variant
- Generation of high-quality reference control panels of human induced pluripotent stem cell clones from PBMCs
- Generation of high-quality reference control panels of human induced pluripotent stem cell clones from fibroblasts
- Generation of a human induced pluripotent stem cell panel from a family with a heterozygous RPS19 mutation including healthy wild-type, silent carrier and Diamond-Blackfan anemia individuals
- Generation of two induced pluripotent stem cell lines from hereditary hemorrhagic telangiectasia patients harboring ACVRL1 mutations
- Generation of TWO iPSC lines (CRICKi025-A and CRICKi026-A) from healthy donor bone marrow mesenchymal stromal cells
- Generation of two human induced pluripotent stem cell lines from patients with hypokalemic periodic paralysis
- Endogenous tagging of the TBXT (Brachyury) gene with 2A-EGFP in BJNhem19 human embryonic stem cells using CRISPR-Cas9 genome editing
- Homology-directed CRISPR-Cas9 correction of the KRT5 p.E475G mutation in human iPSC line from a patient with severe epidermolysis bullosa simplex
- CRISPR/Cpf1-mediated editing of DNM1L in induced pluripotent stem cells
- Two iPSC lines with frameshift mutations in FTSJ1 as models for X-linked non-syndromic intellectual disability
- Generation of isogenic gene-corrected cell lines from a USH2A-RP patient-derived iPS cell line
- Generation and characterization of induced pluripotent stem cells from patients with Marfan syndrome carrying FBN1 variants
- Generation of a doxycycline-inducible NGN2 iPSC line and a GRIA3-edited iPSC resource
- Generation of induced pluripotent stem cell lines from patients with plaque psoriasis and guttate psoriasis
- Generation and characterization of a doxycycline-inducible human induced pluripotent stem cell (hiPSC) line for overexpression of connexin 43 (Cx43)
- Trophoblast giant cell-like cells differentiated directly from ES cells in vitro recapitulate the copy-number landscape of trophoblast giant cells in vivo
- Generation of an induced pluripotent stem cell from a patient with Cornelia de Lange syndrome due to NIPBL mutation
- Generation of a human induced pluripotent stem cell line (ZZUNEUi040-A) from a male patient with hypertrophic cardiomyopathy carrying a heterozygous TPM1 (c.644C > T) mutation
- Generation of a human induced pluripotent stem cell line (PNUYHi004-A) from a patient with hereditary spastic paraplegia type 46 (SPG46) carrying compound heterozygous GBA2 variants
- Characterisation of the patient-specific induced pluripotent stem cell line UKEi075-A carrying the heterozygous PRKAG2 frameshift variant c.769_770del (p.E257Kfs*15)
- Generation of an induced pluripotent stem cell line (SCVli192-A) from a patient with immune checkpoint inhibitor-induced myocarditis and concurrent type 1 diabetes
- Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi012-A) from a patient with Spinocerebellar ataxia type 2
- Generation of an induced pluripotent stem cell line from a Fabry disease patient carrying the GLA c.640-801G>A mutation